Imaging Mass Spectrometry Reveals Tumor Metabolic Heterogeneity

Malignant tumors exhibit high degrees of genomic heterogeneity at the cellular level, leading to the view that subpopulations of tumor cells drive growth and treatment resistance. To examine the degree to which tumors also exhibit metabolic heterogeneity at the level of individual cells, we employed...

Full description

Saved in:

Bibliographic Details
Published in:	iScience Vol. 23; no. 8; p. 101355
Main Authors:	Zhang, Yang, Guillermier, Christelle, De Raedt, Thomas, Cox, Andrew G., Maertens, Ophelia, Yimlamai, Dean, Lun, Mingyue, Whitney, Adam, Maas, Richard L., Goessling, Wolfram, Cichowski, Karen, Steinhauser, Matthew L.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 21-08-2020 Elsevier
Subjects:	Biological Sciences Cancer Systems Biology Biological Sciences Cancer Systems Biology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Malignant tumors exhibit high degrees of genomic heterogeneity at the cellular level, leading to the view that subpopulations of tumor cells drive growth and treatment resistance. To examine the degree to which tumors also exhibit metabolic heterogeneity at the level of individual cells, we employed multi-isotope imaging mass spectrometry (MIMS) to quantify utilization of stable isotopes of glucose and glutamine along with a label for cell division. Mouse models of melanoma and malignant peripheral nerve sheath tumors (MPNSTs) exhibited striking heterogeneity of substrate utilization, evident in both proliferating and non-proliferating cells. We identified a correlation between metabolic heterogeneity, proliferation, and therapeutic resistance. Heterogeneity in metabolic substrate usage as revealed by incorporation of glucose and glutamine tracers is thus a marker for tumor proliferation. Collectively, our data demonstrate that MIMS provides a powerful tool with which to dissect metabolic functions of individual cells within the native tumor environment. [Display omitted] •A method to measure substrate utilization at single cancer cell resolution•Heterogeneity of glucose and glutamine utilization in murine tumors•Metabolic heterogeneity in proliferating and non-proliferating tumor cells•Metabolic heterogeneity correlates with proliferative growth and treatment resistance Biological Sciences; Cancer Systems Biology
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Lead Contact
ISSN:	2589-0042 2589-0042
DOI:	10.1016/j.isci.2020.101355